<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-06-02T19:18:04Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/aur.000006">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/aur.000006</identifier>
									<datestamp>2019-12-12</datestamp>
									<setSpec>PTZ.AUR:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Testicular Cancer Mortality in Chile: Is it as high as we think? 41 years of experience in a single center
										</dc:title><dc:creator>Nicolás Pieressa P</dc:creator><dc:creator> José Rojas C</dc:creator><dc:creator> Carolina Bonomo M</dc:creator><dc:creator> José Villena H</dc:creator><dc:creator> Ítalo Raineri V</dc:creator><dc:creator> Sebastián Oporto U</dc:creator><dc:creator> Cristián Alliende</dc:creator><dc:creator> Miguél Sarrás J</dc:creator><dc:creator> Christopher Horn B</dc:creator><dc:creator> Bruno Vivaldi J</dc:creator><dc:creator> Iván Saez V</dc:creator><dc:creator> Felipe Mandujano T</dc:creator><dc:creator>Fernando Coz</dc:creator><dc:description>&lt;p&gt;Introduction: Testicular cancer carries a good prognosis, with survival rates over 70% at any stage. According to the GLOBOCAN database, Chile has the highest mortality rate worldwide, without a clear explanation of why this is the case. The objective of this study is to contrast the observed deaths in a chilean center during a 41-year period, to the national data previously reported by GLOBOCAN.&lt;/p&gt;&lt;p&gt;Methods: For this retrospective descriptive study, data was retrieved from medical records from every patient diagnosed with testicular cancer between the years 1978-2019 in our center, and their death certificates were assessed for comparison. Histological type, staging, adjuvant treatment, and cause of death, among other variables, were analyzed.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Results: Out of 255 patients diagnosed with testicular cancer, 239(93.7%) were alive at the time of data collection. Out of the 16 recorded deaths, 5(2%) had testicular cancer as cause of death, two out of these five patients had early stage cancers, completed 5 years follow-up without relapse, had multiple comorbidities, and had unspecific information in the death certificate. Thus, testicular cancer cannot be attributed with certainty as the cause of death in those patients.&lt;/p&gt;&lt;p&gt;Conclusion: Chile has the highest mortality rate for testicular cancer worldwide. In our center 40% of the patients that have testicular cancer as cause of death had presumably been incorrectly registered in the death certificate. A possible explanation for the high mortality in Chile could be an incorrect registration of testicular cancer as cause of death.&lt;/p&gt;</dc:description>
										<dc:publisher>Archive of Urological Research - Peertechz Publications</dc:publisher>
										<dc:date>2019-12-12</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/aur.000006</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Nicolás Pieressa P et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
